The Product Launch Tracker

06.10.2023 | Article

Product Launch Tracker: eHCPs had mixed opinions on the updated mRNA COVID-19 booster vaccines.

Discover what healthcare professionals (HCPs) think about pharmaceutical companies

By Alexandra Maria Chatziioannidou

01.09.2023 | Article

Product Launch Tracker: eHCPs thrilled about approval of first oral treatment for postpartum depression

Discover which new drug approvals HCPs are talking about

By Alexandra Maria Chatziioannidou

02.08.2023 | Article

Product Launch Tracker: eHCPs applauded the approval of Opill, the first non-prescription contraceptive.

Discover which new drug approvals HCPs are talking about

By Alexandra Maria Chatziioannidou

08.07.2023 | Article

Product Launch Tracker: eHCPs are delighted with the approval of Talzenna for prostate cancer.

Discover which new drug approvals HCPs are talking about

By Alexandra Maria Chatziioannidou

01.05.2023 | Article

Product Launch Tracker: HCPs are captivated by the approval of Vowst, a faecal microbiota product.

Discover which new drug approvals HCPs are talking about

By Alexandra Maria Chatziioannidou

01.04.2023 | Article

Product Launch Tracker: HCPs are enthusiastic about the approval of two nasal sprays and an antifungal treatment.

Discover which new drug approvals HCPs are talking about

By Alexandra Maria Chatziioannidou

05.02.2023 | Article

Product Launch Tracker: HCPs start the year discussing approvals for Alzheimer’s and several cancer treatments.

HCP's in the month of Jan discussed online their thoughts on a new treatment for Alzheimer’s

By Paul Cranston

15.01.2023 | Article

Product Launch Tracker: HCPs discuss pre-Christmas approvals in precision medicine, oncology and infectious disease

At the start of the month, HCPs were interested in the first faecal microbiota product

By Paul Cranston

16.12.2022 | Article

Product Launch Tracker: HCPs discuss first drug to delay type 1 diabetes and the approval of world’s most expensive treatment

In Nov. 2022 HCPs discussed treatments for multiple myeloma, gene therapy and diabetes.

By Paul Cranston

14.11.2022 | Article

Product Launch Tracker: HCPs share optimism for approvals in heart failure, obesity and multiple myeloma

HCP's shared the news on product approvals for issues like obesity, multiple myeloma, etc.

By Paul Cranston and Tomi Shobande

05.07.2022 | Article

Product Launch Tracker: HCPs discuss approvals including for the prevention of smallpox and monkeypox.

HCPs also held around the approval of treatments for monkeypox

By Paul Cranston and Tomi Shobande

02.07.2022 | Article

Product Launch Tracker: HCPs celebrate 5th agnostic approval in Cancer alongside other approvals

with notable excitement being found for the FDA’s approval of Novartis’ 5th agnostic...

By Paul Cranston and Tomi Shobande